Ultrasound microbubble-mediated RNA interference targeting WNT1 inducible signaling pathway protein 1(WISP1) suppresses the proliferation and metastasis of breast cancer cells

References

• Fahad Ullah M. Breast cancer: current perspectives on the disease status. Adv Exp Med Biol. 2019;1152:51–64.
   PubMed Web of Science ®Google Scholar
• Walker-Smith TL, Peck J. Genetic and Genomic advances in breast cancer diagnosis and treatment. Nurs Women’s Health. 2019;23(6):518–525.
   PubMedGoogle Scholar
• Bottai G, Truffi M, Corsi F, et al. Progress in nonviral gene therapy for breast cancer and what comes next? Expert Opin Biol Ther. 2017;17(5):595–611.
   PubMed Web of Science ®Google Scholar
• de Leon A, Perera R, Nittayacharn P, et al. Ultrasound contrast agents and delivery systems in cancer detection and therapy. Adv Cancer Res. 2018;139:57–84.
   PubMed Web of Science ®Google Scholar
• Yang F, Li Y, Liufu C, et al. Preparation of cationic lipid-coated ultrasound contrast agents and noninvasive gene transfection via ultrasound-targeted microbubble destruction. Curr Pharm Des. 2018;24(30):3587–3595.
   PubMed Web of Science ®Google Scholar
• Chen H, Hwang JH. Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors. J Ther Ultrasound. 2013;1(1):10.
   PubMedGoogle Scholar
• Shi D, Guo L, Sun X, et al. UTMD inhibit EMT of breast cancer through the ROS/miR-200c/ZEB1 axis. Sci Rep. 2020;10(1):6657.
   PubMedGoogle Scholar
• Zhang H, Li Y, Rao F, et al. A novel UTMD system facilitating nucleic acid delivery into MDA-MB-231 cells. Biosci Rep. 2020;40(2) :BSR20192573.
   Web of Science ®Google Scholar
• Endo-Takahashi Y, Maruyama K, Negishi Y. Nucleic acid delivery system by the combination of lipid bubbles and ultrasound. Curr Pharm Des. 2018;24(23):2673–2677.
   PubMed Web of Science ®Google Scholar
• Han H. RNA interference to knock down gene expression. Methods Mol Biol. 2018;1706:293–302.
   PubMedGoogle Scholar
• Zhao R, Liang X, Zhao B, et al. Ultrasound assisted gene and photodynamic synergistic therapy with multifunctional FOXA1-siRNA loaded porphyrin microbubbles for enhancing therapeutic efficacy for breast cancer. Biomaterials. 2018;173:58–70.
   PubMed Web of Science ®Google Scholar
• Berschneider B, Königshoff M. WNT1 inducible signaling pathway protein 1 (WISP1): a novel mediator linking development and disease. Int J Biochem Cell Biol. 2011;43(3):306–309.
   PubMed Web of Science ®Google Scholar
• Kleer CG. Dual roles of CCN proteins in breast cancer progression. J Cell Commun Signal. 2016;10(3):217–222.
   PubMed Web of Science ®Google Scholar
• Gurbuz I, Chiquet-Ehrismann R. CCN4/WISP1 (WNT1 inducible signaling pathway protein 1): a focus on its role in cancer. Int J Biochem Cell Biol. 2015;62:142–146.
   PubMed Web of Science ®Google Scholar
• Deng W, Fernandez A, McLaughlin SL, et al. WNT1-inducible signaling pathway protein 1 (WISP1/CCN4) stimulates melanoma invasion and metastasis by promoting the epithelial-mesenchymal transition. J Biol Chem. 2019;294(14):5261–5280.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang SH, Hsu PW, Chien, SY, Wang, CQ, Su, CM, et al. Impact of WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of breast cancer. Medicine. 2019;98(44):e17854.
   Web of Science ®Google Scholar
• Clausen MJ, Melchers LJ, Mastik MF, et al. Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma. Genes Chromosomes Cancer. 2016;55:45–59.
   PubMed Web of Science ®Google Scholar
• Nagai Y, Watanabe M, Ishikawa S, et al. Clinical significance of Wnt-induced secreted protein-1 (WISP-1/CCN4) in esophageal squamous cell carcinoma. Anticancer Res. 2011;31(3):991–997.
   PubMed Web of Science ®Google Scholar
• Yang JY, Yang MW, Huo YM, et al. High expression of WISP-1 correlates with poor prognosis in pancreatic ductal adenocarcinoma. Am J Transl Res. 2015;7(9):1621–1628.
   PubMed Web of Science ®Google Scholar
• Gurbuz I, Ferralli J, Roloff T, et al. SAP domain-dependent Mkl1 signaling stimulates proliferation and cell migration by induction of a distinct gene set indicative of poor prognosis in breast cancer patients. Mol Cancer. 2014;13(1):22.
   PubMedGoogle Scholar
• Chiang KC, Yeh CN, Chung LC, et al. WNT-1 inducible signaling pathway protein-1 enhances growth and tumorigenesis in human breast cancer. Sci Rep. 2015;5(1):8686.
   PubMedGoogle Scholar
• Klinke DJ, Shvartsman S. Induction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study. PLoS Comput Biol. 2014;10(1):e1003409.
   PubMed Web of Science ®Google Scholar
• Ran LW, Wang H, Lan D, et al. Effect of RNA interference targeting STAT3 gene combined with ultrasonic irradiation and sonovue microbubbles on proliferation and apoptosis in keratinocytes of psoriatic lesions. Chin Med J (Engl). 2018;131(17):2097–2104.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego Calif). 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Chowdhury SM, Abou-Elkacem L, Lee T, et al. Ultrasound and microbubble mediated therapeutic delivery: underlying mechanisms and future outlook. J Control Release. 2020;326:75–90.
   PubMed Web of Science ®Google Scholar
• Roovers S, Segers T, Lajoinie G, et al. The role of ultrasound-driven microbubble dynamics in drug delivery: from microbubble fundamentals to clinical translation. Langmuir. 2019;35(31):10173–10191.
   PubMed Web of Science ®Google Scholar
• Huang CL, Liu D, Masuya D, et al. MRP-1/CD9 gene transduction downregulates Wnt signal pathways. Oncogene. 2004;23(45):7475–7483.
   PubMed Web of Science ®Google Scholar
• Pennica D, Swanson TA, Welsh JW, et al. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proceedings of the National Academy of Sciences of the United States of America, USA. 1998; 95:14717–14722.
   Google Scholar
• Gaudreau PO, Clairefond S, Class CA, et al. WISP1 is associated to advanced disease, EMT and an inflamed tumor microenvironment in multiple solid tumors. Oncoimmunology. 2019;8(5):e1581545.
   PubMed Web of Science ®Google Scholar
• Hu R, Tian C, Meng WJ, et al. The expression and clinical significance of Wnt-1 induced secreted protein-1 in breast carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban. 2010;41(2):231–234.
   PubMedGoogle Scholar
• Feng M, Jia S. Dual effect of WISP-1 in diverse pathological processes. Chin J Cancer Res. 2016;28(6):553–560.
   PubMed Web of Science ®Google Scholar
• Sirsi SR, Borden MA. Advances in ultrasound mediated gene therapy using microbubble contrast agents. Theranostics. 2012;2(12):1208–1222.
   PubMed Web of Science ®Google Scholar
• Lee H, Kim H, Han H, et al. Microbubbles used for contrast enhanced ultrasound and theragnosis: a review of principles to applications. Biomed Eng Lett. 2017;7(2):59–69.
   PubMed Web of Science ®Google Scholar
• Korosoglou G, Hardt SE, Bekeredjian R, et al. Ultrasound exposure can increase the membrane permeability of human neutrophil granulocytes containing microbubbles without causing complete cell destruction. Ultrasound Med Biol. 2006;32(2):297–303.
   PubMed Web of Science ®Google Scholar
• Karshafian R, Bevan PD, Williams R, et al. Sonoporation by ultrasound-activated microbubble contrast agents: effect of acoustic exposure parameters on cell membrane permeability and cell viability. Ultrasound Med Biol. 2009;35(5):847–860.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li X, Liu L, et al. Tissue targeting and ultrasound-targeted microbubble destruction delivery of plasmid DNA and transfection in vitro. Cell Mol Bioeng. 2020;13(1):99–112.
   PubMed Web of Science ®Google Scholar
• Chen ZY, Liang K, Sheng XJ, et al. Optimization and apoptosis induction by RNAi with UTMD technology in vitro. Oncol Lett. 2012;3(5):1030–1036.
   PubMed Web of Science ®Google Scholar
• Ji Y, Han Z, Shao L, et al. Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer. Cancer Med. 2016;5(9):2534–2543.
   PubMed Web of Science ®Google Scholar
• Ji Y, Han Z, Shao L, et al. Ultrasound-targeted microbubble destruction of calcium channel subunit α 1D siRNA inhibits breast cancer via G protein-coupled receptor 30. Oncol Rep. 2016;36(4):1886–1892.
   PubMed Web of Science ®Google Scholar
• Luo H, Li J, Lin Q, et al. Ultrasonic irradiation and SonoVue microbubbles-mediated RNA interference targeting PRR11 inhibits breast cancer cells proliferation and metastasis, but promotes apoptosis. Biosci Rep. 2020;40(11):BSR20201854.
   Web of Science ®Google Scholar
• Tang X, Hao N, Zhou Y, et al. Ultrasound targeted microbubble destruction-mediated SOCS3 attenuates biological characteristics and epithelial-mesenchymal transition (EMT) of breast cancer stem cells. Bioengineered. 2022;13(2):3896–3910.
   PubMed Web of Science ®Google Scholar